
Sign up to save your podcasts
Or
AI has the potential to revolutionize clinical trials in many ways. It could make the development of new treatments faster, safer, cheaper and more personalised. One company in this space is Owkin, a unicorn startup based in Paris. With me is Dr Félix Balazard, Director of
4
44 ratings
AI has the potential to revolutionize clinical trials in many ways. It could make the development of new treatments faster, safer, cheaper and more personalised. One company in this space is Owkin, a unicorn startup based in Paris. With me is Dr Félix Balazard, Director of
766 Listeners
11,150 Listeners
30,950 Listeners
43,452 Listeners
6,444 Listeners
616 Listeners
8,781 Listeners
352 Listeners
5,387 Listeners
99 Listeners
20 Listeners
50 Listeners
124 Listeners
436 Listeners
957 Listeners